Neupro Titration Kit for Parkinson's disease Pack

RxCUI: 1360633
RxNorm name: Neupro Titration Kit for Parkinson's disease Pack
Display name: Neupro Titration Kit for Parkinson's disease Pack
Full name: Neupro Titration Kit for Parkinson's disease Pack
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Neupro	ROTIGOTINE	UCB, Inc.	939e28c5-f3a9-42c0-9a2d-8d471d82a6e0	2025-06-24	Warnings, Adverse reactions	Exact identifier rxcui: 1360633

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
939e28c5-f3a9-42c0-9a2d-8d471d82a6e0	Neupro Titration Kit for Parkinson's disease Pack	PSN	20	These highlights do not include all the information needed to use NEUPRO safely and effectively. See full prescribing information for NEUPRO. NEUPRO (rotigotine transdermal system) Initial U.S. Approval: 2007	20250624
939e28c5-f3a9-42c0-9a2d-8d471d82a6e0	Neupro Titration Kit for Parkinson's disease	SY	20	These highlights do not include all the information needed to use NEUPRO safely and effectively. See full prescribing information for NEUPRO. NEUPRO (rotigotine transdermal system) Initial U.S. Approval: 2007	20250624
939e28c5-f3a9-42c0-9a2d-8d471d82a6e0	{7 (24 HR rotigotine 0.0833 MG/HR Transdermal System [Neupro]) / 7 (24 HR rotigotine 0.167 MG/HR Transdermal System [Neupro]) } Pack [Neupro Kit]	BPCK	20	These highlights do not include all the information needed to use NEUPRO safely and effectively. See full prescribing information for NEUPRO. NEUPRO (rotigotine transdermal system) Initial U.S. Approval: 2007	20250624